Peter Ravn

Peter Ravn is currently the Director at Servier Symphogen and has held various leadership positions in antibody technology, including Director of Antibody Engineering and Biochemistry at Lundbeck and Team Leader at AstraZeneca. Peter's early career included roles such as Senior Scientist and Project Leader at MedImmune, where they specialized in antibody discovery and protein engineering. Peter earned a PhD in Biotechnology from Freie Universität Berlin and a Master's degree in Biotechnology/Chemistry from Aarhus University. They also served as a Research Fellow at UCL in the Department of Oncology.